Articles: 26.04 19 February 2015

A profile of the various forms of urticaria and how to treat them

There are various types of urticaria and, while generally easy to diagnose, it can be confusing. It is also important to recognise when to refer to secondary care.
A profile of the various forms of urticaria and how to treat them

More details...

Advances in the diagnosis and management of dyslipidaemia

Tackling the early stages of dyslipidaemia can help in the reduction of the risk of CVD. Our drug review outlines primary and secondary prevention measures and the need for patient-centred care which includes individual assessment of overall cardiovascular risk, followed by an analysis of the …

More details...

Anoro Ellipta: dry powder LAMA/ LABA combination for COPD

Anoro Ellipta is the first inhaler to combine a LAMA and a LABA in a single unit. Here we present the clinical data relating to its efficacy and adverse events and look at its place in the management of COPD.
Anoro Ellipta dry powder LAMA LABA …

More details...

Health Survey for England 2013: the use of prescribed medicines

In 2013, for the first time, the annual Health Survey for England sought information on medicines use within the community. Here we examine the results.
Health Survey for England 2013 the use of prescribed medicines

More details...

Is the UK too slow in the uptake of new medicines?

According to the ABPI the UK is slow to introduce new medicines across a range of categories. In this article we look at how the UK’s use of new medicines compares with other countries and question how meaningful the ranking system is.
Is the UK too …

More details...

New from NICE

In this update to the 2007 guideline (CG45), NICE has revised everything except its recommendations on service organisation. It covers the recognition, assessment, care and treatment of mental health in women planning a pregnancy, during pregnancy and up to one year after childbirth.
New from NICE

More details...

Polypharmacy – appropriate, problematic or both?

In the second article of our polypharmacy series the authors explore the difference between appropriate and problematic polypharmacy, and illustratehow in some circumstances these two states can co-exist.
Polypharmacy appropriate, problematic or both

More details...

Updated NICE guidance on the management of dyspepsia

Dyspepsia is a frequent symptom, with prevalence estimated between 19 –41 per cent in a recent meta-analysis in Europe. It accounts for approximately 2–5 per cent of all visits to GPs. Prescribed drugs and endoscopies currently cost the NHS £600 million annually.
Updated NICE guidance on …

More details...

Web design and marketing agency Leamington Spa